FrancophonIA/ELRC3.0 huggingface dataset:
English: Truxima slows down the damage to your joints caused by rheumatoid arthritis and improves your ability to do normal daily activities.
Slovenian: Zdravilo Truxima upočasni nastanek okvar sklepov, ki so posledica revmatoidnega artritisa, ter izboljša vašo sposobnost za opravljanje običajnih dnevnih aktivnosti.
English: It is not known whether Truxima has an effect on you being able to drive or use any tools or machines.
Slovenian: Ni znano, ali zdravilo Truxima vpliva na vašo sposobnost za upravljanje vozil ali strojev.
English: Truxima is usually taken together with another medicine called methotrexate.
Slovenian: Zdravilo Truxima se običajno jemlje skupaj z zdravilom, imenovanim metotreksat.
English: c)
Slovenian: d)
English: Your doctor may need to take special care of you during your treatment with Truxima.
Slovenian: Zdravnik bo morda moral biti med zdravljenjem z zdravilom Truxima posebej poskrbeti za vas.
English: * Infusion-related reactions included symptoms collected on the next scheduled visit after each infusion, and adverse events occurring on the day of or one day after the infusion.
Slovenian: kožni papilomi * Z infundiranjem povezane reakcije so vključevale simptome, zbrane ob naslednjem načrtovanem obisku po vsaki infuziji, in neželene dogodke, ki so se pojavili na dan infuzije ali en dan po njej.
English: This is because there is not much information about the use of Truxima in children and young people.
Slovenian: O uporabi zdravila Truxima pri otrocih in mladostnikih namreč ni veliko informacij.
English: How Truxima is given How it is given
Slovenian: Kako se daje zdravilo Truxima Kako se zdravilo daje
English: Truxima may be used for the treatment of several different conditions in adults.
Slovenian: Zdravilo Truxima se uporablja za zdravljenje več različnih bolezni pri odraslih.
English: What you need to know before you use Truxima Do not take Truxima if:
Slovenian: Kaj morate vedeti, preden boste uporabili zdravilo Truxima Ne uporabljajte zdravila Truxima, če:
English: • If you respond well to treatment, you may be given Truxima every 2 or 3 months for two years.
Slovenian: Če se boste dobro odzvali na zdravljenje, boste lahko zdravilo Truxima dobivali na dva meseca ali tri, in sicer dve leti.
English: Tell your doctor immediately if you get signs of an infection including:
Slovenian: Zdravniku nemudoma povejte, če se vam pojavijo znaki okužbe, na primer:
English: • heart beating faster than normal
Slovenian: hitrejše bitje srca kot običajno.
English: For patients who may be at higher risk for relapse, physicians should consider a longer duration of Truxima maintenance therapy, up to 5 years.
Slovenian: Pri bolnikih z večjim tveganjem za recidiv je treba razmisliti o dolgotrajnejšem vzdrževalnem zdravljenju z zdravilom Truxima, do 5 let.
English: What Truxima is and what it is used for What you need to know before you use Truxima How to use Truxima
Slovenian: Kaj je zdravilo Truxima in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo Truxima Kako uporabljati zdravilo Truxima
English: Other rarely-reported side-effects due to Truxima include a decreased number of white cells in the blood (neutrophils) that help to fight against infection.
Slovenian: Drugi neželeni učinki zdravila Truxima, o katerih so poročali redko, vključujejo zmanjšano število belih krvnih celic (nevtrofilcev), ki pomagajo v boju proti okužbam.
English: When you are treated with Truxima in combination with chemotherapy, you will receive Truxima infusions on day 0 cycle 1 then day 1 of each cycle for 6 cycles in total.
Slovenian: Ko se boste zdravili z zdravilom Truxima v kombinaciji s kemoterapijo, boste dobili infuzijo zdravila Truxima 0. dan 1. cikla in nato 1. dan vsakega naslednjega cikla, skupaj 6 ciklov.
English: This is because Truxima can across the placenta and may affect your baby.
Slovenian: Zdravilo Truxima namreč prehaja skozi posteljico (placento) in lahko škoduje otroku.
English: This is because some people have a fall in their blood pressure while they are being given Truxima.
Slovenian: Nekaterim ljudem se namreč med prejemanjem zdravila Truxima krvni tlak zniža;
English: Only limited data are available on efficacy and safety for patients previously treated with monoclonal antibodies including Truxima or patients refractory to previous Truxima plus chemotherapy.
Slovenian: Na voljo so le omejeni podatki glede učinkovitosti in varnosti pri bolnikih, ki so se predhodno zdravili z monoklonskimi protitelesi, vključno z zdravilom Truxima, ali pri bolnikih, ki se na prejšnje zdravljenje z zdravilom Truxima in kemoterapijo niso odzvali.
English: Truxima should be used in combination with CHOP chemotherapy.
Slovenian: Zdravilo Truxima je treba uporabljati v kombinaciji s kemoterapijo CHOP.
English: Retreatment should be given at that time if residual disease activity remains, otherwise retreatment should be delayed until disease activity returns.
Slovenian: Ob tem času je treba bolnika ponovno zdraviti, če je bolezen še vedno aktivna, sicer pa se ponovno zdravljenje odloži,
English: Your doctor may prescribe Truxima for the treatment of:
Slovenian: Zdravnik vam lahko zdravilo Truxima predpiše za zdravljenje:
English: Truxima in combination with methotrexate is indicated for the treatment of adult patients with severe active rheumatoid arthritis who have had an inadequate response or intolerance to other disease-modifying anti-rheumatic drugs (DMARD) including one or more tumour necrosis factor (TNF) inhibitor therapies.
Slovenian: Zdravilo Truxima je v kombinaciji z metotreksatom indicirano za zdravljenje odraslih bolnikov z zelo aktivnim revmatoidnim artritisom, ki niso zadostno odgovorili na druga imunomodulirajoča zdravila (DMARD, disease-modifying anti-rheumatic drugs), vključno z enim ali več zaviralci tumorje nekrotizirajočega faktorja (TNF), ali jih niso prenašali.
English: Contraindications for use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia Hypersensitivity to the active substance or to murine proteins, or to any of the other excipients listed in section 6.1.
Slovenian: Kontraindikacije za uporabo pri ne-Hodgkinovem limfomu in kronični limfocitni levkemiji Preobčutljivost na zdravilno učinkovino ali mišje beljakovine ali na katero koli drugo pomožno snov, navedeno v poglavju 6.1.
English: When Truxima is given in combination with chemotherapy, standard dose reductions for the chemotherapeutic medicinal products should be applied.
Slovenian: Če zdravilo Truxima uporabimo v kombinaciji s kemoterapijo, je treba uporabiti standardno zmanjšanje odmerkov citostatikov.
English: Truxima is indicated for the treatment of patients with CD20 positive diffuse large B cell non-Hodgkin's lymphoma in combination with CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) chemotherapy.
Slovenian: Zdravilo Truxima je indicirano za zdravljenje bolnikov s CD20-pozitivnim difuznim velikoceličnim B ne-Hodgkinovim limfomom v kombinaciji s kemoterapijo CHOP (ciklofosfamid, doksirubicin, vinkristin, prednizolon).
English: B-lymphocytes are involved in the cause of some of the symptoms you have.
Slovenian: Limfociti B sodelujejo pri nastanku nekaterih simptomov, ki jih imate.
English: Safety and efficacy of Truxima have not been established in combination with other chemotherapies in diffuse large B cell non-Hodgkin's lymphoma.
Slovenian: Varnosti in učinkovitosti zdravila Truxima v kombinaciji z drugimi kemoterapijami pri difuznem velikoceličnem B ne-Hodgkinovem limfomu niso ugotavljali.
English: Truxima contains sodium
Slovenian: Zdravilo Truxima vsebuje natrij
English: The proportion of patients experiencing an infusion-related reaction was 29% (11 patients), 40% (15 patients), 13% (5 patients), and 10% (4
Slovenian: Delež bolnikov, ki se jim je pojavila z infundiranjem povezana reakcija, je bil po prvem infundiranju 29% (11 bolnikov), po drugem 40% (15 bolnikov), po tretjem 13% (5 bolnikov) in po četrtem 10% (4 bolniki).
English: Following induction of remission with other standard of care immunosuppressants, Truxima maintenance treatment should be initiated during the 4 week period that follows disease remission.
Slovenian: Po indukciji remisije z drugimi imunosupresivi, ki spadajo v okvir običajnega zdravljenja, je treba vzdrževalno zdravljenje z zdravilom Truxima začeti v 4-tedenskem obdobju po remisiji bolezni.
English: Following induction of remission with Truxima, maintenance treatment should be initiated no sooner than 16 weeks after the last Truxima infusion.
Slovenian: Po indukciji remisije z zdravilom Truxima se vzdrževalnega zdravljenja ne sme začeti prej kot 16 tednov po zadnji infuziji zdravila Truxima.
English: 1 mg/kg/day (not to exceed 80 mg/day, and tapered as rapidly as possible based on clinical need) during and after the 4 week induction course of Truxima treatment.
Slovenian: 1 mg/kg/dan prednizona peroralno (odmerek ne sme preseči 80 mg/dan in ga je treba zmanjšati, kolikor hitro je mogoče glede na klinične potrebe) med in po 4-tedenskem indukcijskem zdravljenjem z zdravilom Truxima in po njem.
English: • allergic reactions including wheezing or shortness of breath, swelling of the face and tongue, collapse
Slovenian: alergijske reakcije, vključno s piskanjem ali kratko sapo, otekanjem obraza in jezika ter kolapsom.
English: A. MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURERS RESPONSIBLE FOR BATCH RELEASE
Slovenian: A. IZDELOVALEC BIOLOŠKE UČINKOVINE IN IZDELOVALCI, ODGOVORNI ZA
English: Talk to your doctor, pharmacist or nurse before you are given Truxima if:
Slovenian: Posvetujte se z zdravnikom, farmacevtom ali medicinsko sestro, preden dobite zdravilo Truxima:
English: If you are having Truxima with other medicines, some of the side effects you may get may be due to the other medicines.
Slovenian: Če prejemate zdravilo Truxima skupaj z drugimi zdravili, se nekateri neželeni učinki lahko pojavijo zaradi drugih zdravil.
English: Truxima can be given alone or with other medicines called “chemotherapy”.
Slovenian: Zdravilo Truxima lahko uporabljamo samostojno ali skupaj z drugimi zdravili, ki jih imenujemo kemoterapija.
English: • If you are having Truxima with chemotherapy Truxima will be given to you on the same day as your chemotherapy.
Slovenian: Če prejemate zdravilo Truxima skupaj s kemoterapijo, ga boste dobili isti dan kot kemoterapijo.
English: Truxima maintenance therapy is indicated for the treatment of follicular lymphoma patients responding to induction therapy.
Slovenian: Vzdrževalno zdravljenje z zdravilom Truxima je indicirano za zdravljenje bolnikov s folikularnimi limfomi, ki se odzovejo na indukcijsko zdravljenje.
English: What Truxima looks like and contents of the pack
Slovenian: Izgled zdravila Truxima in vsebina pakiranja
English: Medicines given before each Truxima administration
Slovenian: Zdravila, ki jih boste dobili pred vsakim dajanjem zdravila Truxima
English: Truxima is a biosimilar medicinal product.
Slovenian: Zdravilo Truxima je podobno biološko zdravilo.
English: In patients with granulomatosis with polyangiitis (Wegener's) or microscopic polyangiitis, methylprednisolone given intravenously for 1 to 3 days at a dose of 1000 mg per day is recommended prior to the first infusion of Truxima (the last dose of methylprednisolone may be given on the same day as the first infusion of Truxima).
Slovenian: Pri bolnikih z granulomatozo s poliangiitisom (Wegenerjevo granulomatozo) ali mikroskopskim poliangiitisom je pred prvo infuzijo zdravila Truxima priporočljiva intravenska uporaba metilprednizolona, ki se ga daje od 1 do 3 dni v odmerku 1000 mg na dan (zadnji odmerek metilprednizolona je lahko uporabljen na dan prve infuzije zdravila Truxima).
English: The recommended dosage of Truxima is 1000 mg by intravenous infusion followed by a second 1000 mg intravenous infusion two weeks later.
Slovenian: Priporočeni odmerek zdravila Truxima je 1.000 mg z intravensko infuzijo, čemur sledi druga intravenska infuzija 1.000 mg 2 tedna pozneje.
English: This is because in a few cases, Truxima could cause hepatitis B to become active again, which can be fatal in very rare cases.
Slovenian: V maloštevilnih primerih namreč lahko bolezen zaradi zdravila Truxima ponovno izbruhne; to je lahko v zelo redkih primerih smrtno.
English: A subsequent analysis of the duration of overall survival, carried out with a median follow-up duration of 60 months, confirmed the benefit of R-CHOP over CHOP treatment (p=0.0071), representing a risk reduction of 32%.
Slovenian: Nadaljnja analiza trajanja celokupnega preživetja, ki so jo izvedli po mediani časa sledenja 60 mesecev, je potrdila prednost zdravljenja z R-CHOP pred CHOP (p=0,0071), kar pomeni zmanjšanje tveganja za dogodke za 32%.
English: Truxima is used for the treatment of granulomatosis with polyangiitis (formerly called Wegener's granulomatosis) or microscopic polyangiitis, taken in combination with corticosteroids.
Slovenian: Zdravilo Truxima se uporablja za zdravljenje granulomatoze s poliangiitisom (prej imenovane Wegenerjeva granulomatoza) ali mikroskopskega poliangiitisa; daje se v kombinaciji s kortikosteroidi.
English: Treatment with Truxima uses four separate infusions given at weekly intervals.
Slovenian: Zdravljenje z zdravilom Truxima obsega štiri ločene infuzije, ki jih dobite v presledkih enega tedna.
English: • changes in the rhythm of the heart, or the heart beating faster than normal
Slovenian: spremembe v srčnem ritmu ali hitrejše (kot je običajno) bitje srca.
English: • The need to monitor patients for infections, especially PML, during and after Truxima treatment
Slovenian: • informacije o nujnosti, da bolnike spremljajo zaradi nastanka mogočih okužb, posebno progresivne multifokalne levkoencefalopatije (PML), med zdravljenjem z zdravilom Truxima in po njem,
English: • Signs of PML include: - Confusion, memory loss or problems thinking - Loss of balance or a change in the way you walk or talk - Decreased strength or weakness on one side of your body - Blurred vision or loss of vision.
Slovenian: - izgubo ravnotežja ali spremembo v načinu govora ali hoje, - zmanjšano moč ali šibkost na eni strani telesa, - zamegljen vid ali izgubo vida.
English: Patients who have clinically significant cardiovascular disease, including arrhythmias, or previous serious infusion reactions to any prior biologic therapy or to rituximab, should not be administered the more rapid infusion.
Slovenian: Bolniki s klinično pomembno srčno-žilno boleznijo, vključno z aritmijami, ali resno reakcijo, povezano z infuzijo na katero koli biološko zdravilo ali na rituksimab, ne smejo prejeti hitrejše infuzije.
English: In patients treated with cyclophosphamide (followed by azathioprine for maintenance of complete remission), 39% of patients achieved CR at 12 months, and 33% of patients achieved CR at 18 months.
Slovenian: Med bolniki, zdravljenimi s ciklofosfamidom (ki mu je sledil azatioprin za vzdrževanje popolne remisije) je 39% bolnikov doseglo popolno remisijo po 12 mesecih in 33% bolnikov po 18 mesecih.
English: In patients with rheumatoid arthritis, granulomatosis with polyangiitis (Wegener's) or microscopic polyangiitis in disease remission or pemphigus vulgaris, premedication with 100 mg intravenous methylprednisolone should be completed 30 minutes prior to Truxima infusions to decrease the incidence and severity of infusion related reactions (IRRs).
Slovenian: Pri bolnikih z revmatoidnim artritisom, granulomatozo s poliangiitisom (Wegenerjevo granulomatozo), mikroskopskim poliangiitisom v remisiji ali navadnim pemfigusom je treba 30 minut pred pričetkom infundiranja zdravila Truxima zaključiti z intravenskim dajanjem 100 mg metilprednizolona za zmanjšanje incidence in resnosti reakcij, povezanih z infuzijo.
English: What Truxima is and what it is used for What Truxima is
Slovenian: Kaj je zdravilo Truxima in za kaj ga uporabljamo Kaj je zdravilo Truxima
English: If you are not sure, talk to your doctor, pharmacist or nurse before you are given Truxima.
Slovenian: Če ste negotovi, se posvetujte z zdravnikom, farmacevtom ali medicinsko sestro, preden dobite zdravilo Truxima.
English: Repeated treatment courses with Truxima are possible.
Slovenian: Zdravljenje z zdravilom Truxima se lahko ponovi.
English: +myocardial infarction4 and 6, arrhythmia, +atrial fibrillation, tachycardia, +cardiac disorder
Slovenian: +miokardni infarkt4 in 6, aritmija, +atrijska fibrilacija, tahikardija,
English: Granulomatosis with polyangiitis and microscopic polyangiitis Truxima, in combination with glucocorticoids, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (Wegener's) (GPA) and microscopic polyangiitis (MPA).
Slovenian: Granulomatoza s poliangiitisom in mikroskopski poliangiitis Zdravilo Truxima je v kombinaciji z glukokortikoidi indicirano za zdravljenje odraslih bolnikov s hudo, aktivno granulomatozo s poliangiitisom (GPA, Wegenerjevo granulomatozo) in z mikroskopskim poliangiitisom (MPA).
English: Truxima should be administered on day 1 of each chemotherapy cycle, after intravenous administration of the glucocorticoid component of the chemotherapy if applicable.
Slovenian: Zdravilo Truxima je treba dajati prvi dan vsakega cikla kemoterapije po uporabi glukokortikoidne sestavine kemoterapije, če jo shema vsebuje.
English: • The need to check, prior to Truxima treatment, for infections, for immunosuppression, for prior/current medication affecting the immune system and recent history of, or planned, vaccination
Slovenian: • informacije o nujnosti, da pred dajanjem zdravila Truxima preverijo, ali je bolnik morda okužen, imunsko oslabljen, ali jemlje zdravila, ki vplivajo na imunski sistem, ali jih je jemal v preteklosti, ali se je nedavno cepili oziroma to namerava,
English: Psychiatric depression, anxiety
Slovenian: Psihiatrične motnje depresija, anksioznost
English: The mean Cmax (N=15) was 408 µg/mL (range, 97 - 764 µg/mL) after the fifth 500 mg/ m2 infusion and the mean terminal half-life was 32 days (range, 14 - 62 days).
Slovenian: je bila 408 µg/ml (od 97 do 764 µg/ml) po peti infuziji 500 mg/m2, povprečni končni razpolovni čas pa je bil 32 dni (od 14 do 62 dni).
English: Patients treated with Truxima must be given the patient alert card with each infusion.
Slovenian: Bolniki, ki prejemajo zdravilo Truxima, morajo ob vsaki infuziji dobiti opozorilno kartico.
English: Truxima is indicated for the treatment of previously untreated patients with stage III-IV follicular lymphoma in combination with chemotherapy.
Slovenian: Zdravilo Truxima je indicirano za zdravljenje predhodno nezdravljenih bolnikov s III. in IV. stadijem folikularnih limfomov v kombinaciji s kemoterapijo.
English: Granulomatosis with polyangiitis and microscopic polyangiitis Patients treated with Truxima must be given the patient alert card with each infusion.
Slovenian: Granulomatoza s poliangiitisom in mikroskopski poliangiitis Bolniku je treba ob vsaki infuziji zdravila Truxima dati kartico za bolnike.
English: Subsequent doses of Truxima can be infused at an initial rate of 100 mg/h, and increased by 100 mg/h increments at 30 minute intervals, to a maximum of 400 mg/h.
Slovenian: Nadaljnje odmerke zdravila Truxima lahko dajemo z začetno hitrostjo 100 mg/h, ki jo lahko vsakih 30 minut povečujemo po 100 mg/h, dokler ne dosežemo največje hitrosti infundiranja 400 mg/h.
English: Initial treatment, bulky disease, weekly for 4 doses
Slovenian: Začetno zdravljenje, obsežna bolezen, 4 odmerki, enkrat na teden
English: The Patient information about Truxima should contain the following key elements:
Slovenian: Gradivo za bolnika o zdravilu Truxima mora vsebovati naslednje ključne vsebine:
English: Truxima works best in those who have a positive blood test to rheumatoid factor (RF) and/or anti-cyclic citrullinated peptide (anti-CCP).
Slovenian: Na zdravljenje z zdravilom Truxima se najbolje odzovejo tisti bolniki, pri katerih je krvni test za revmatoidni faktor (RF) in/ali anti-ciklični citrulinirani peptid (anti-CCP) pozitiven.
English: • a feeling of fullness or a throbbing pain behind the nose, cheeks and eyes (sinusitis), pain in the abdomen, vomiting and diarrhoea, breathing problems
Slovenian: občutek zamašenosti ali utripajoča bolečina za nosom, lici in očmi (sinuzitis), bolečina v trebuhu, bruhanje in driska, težave z dihanjem,
English: In the CLL first-line study, Binet stage C patients experienced more adverse events in the R-FC arm compared to the FC arm (R-FC 83% vs. FC 71%).
Slovenian: V študiji pri bolnikih s KLL v prvi liniji zdravljenja so imeli bolniki s stopnjo C po Binetu več neželenih dogodkov v skupini R-FC v primerjavi s skupino FC (R-FC 83% proti
English: Aseptically withdraw the necessary amount of Truxima, and dilute to a calculated concentration of 1 to 4 mg/mL rituximab into an infusion bag containing sterile, pyrogen-free sodium chloride 9 mg/mL (0.9%) solution for injection or 5% D-Glucose in water.
Slovenian: Aseptično odvzamemo potrebno količino rituksimaba in jo razredčimo, da dobimo izračunano koncentracijo od 1 do 4 mg/ml rituksimaba v infuzijski vrečki, ki vsebuje sterilno apirogeno 0,9-%
English: Each course of treatment is made up of two separate infusions which are given 2 weeks apart.
Slovenian: Vsako zdravljenje sestavljata dve ločeni infuziji, ki ju boste prejeli z dvotedenskim premorom.
English: This medicinal product contains 52.6 mg sodium per 10 mL vial, equivalent to 2.6% of the WHO recommended maximum daily intake of 2 g sodium for an adult.
Slovenian: To zdravilo vsebuje 52,6 mg natrija na 10 mL viale, kar je enako 2,6% največjega dnevnega vnosa natrija za odrasle osebe, ki ga priporoča SZO in znaša 2 g.
English: TTP - Time to progression or death PFS - Progression-Free Survival TTF - Time to Treatment Failure OS rates - survival rates at the time of the analyses
Slovenian: TTP: čas do napredovanja bolezni ali smrti (Time to progression or death) PFS: preživetje brez napredovanja bolezni (Progression-Free Survival) TTF: čas do neuspeha zdravljenja (Time to Treatment Failure) Deleži OS (celokupnega preživetja - Overall survival): deleži preživetja ob času analiz ORR: celokupni odgovor (Overall Response Rate)
English: The prepared Truxima solution should be administered as an intravenous infusion through a dedicated line.
Slovenian: Pripravljeno raztopino zdravila Truxima dajemo kot intravensko infuzijo skozi poseben kanal.
English: In a non-randomised study, patients with relapsed low-grade NHL who received rituximab monotherapy when compared to healthy untreated controls had a lower rate of response to vaccination with tetanus recall antigen (16% vs. 81%) and Keyhole Limpet Haemocyanin (KLH) neoantigen (4% vs. 76% when assessed for >2-fold increase in antibody titer).
Slovenian: V nerandomizirani študiji so imeli bolniki, ki so prejeli samostojno zdravljenje z rituksimabom ob ponovitvi nizkomalignega NHL, v primerjavi z zdravimi kontrolnimi osebami, ki niso prejele zdravila, v manjšem deležu dogovorili nižji delež odgovora na cepljenje s cepivom proti tetanusu (recall antigen) (16% v primerjavi z 81%) in neoantigenom KLH (Keyhole Limpet Haemocyanin) (4% v primerjavi s
English: Also do not breast-feed for 12 months after your last treatment with Truxima.
Slovenian: Prav tako ne smete dojiti še 12 mesecev po zadnjem odmerku zdravila Truxima.
English: Contents of the pack and other information
Slovenian: Shranjevanje zdravila Truxima Vsebina pakiranja in dodatne informacije
English: (≥ 1/100 to < 1/10), uncommon (≥ 1/1000 to < 1/100) and very rare (< 1/10000).
Slovenian: pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100), redki (≥ 1/10.000 do < 1/1.000), zelo redki
English: What Truxima is used for
Slovenian: Za kaj uporabljamo zdravilo Truxima
English: A course of Truxima consists of two 1000 mg intravenous infusions.
Slovenian: Cikel zdravljenja z zdravilom Truxima je sestavljen iz dveh 1000 mg intravenskih infuzij.
English: The Patient Alert Card for Truxima in non-oncology indications should contain the following key elements:
Slovenian: Opozorilna kartica za bolnika z neonkološko indikacijo mora vsebovati naslednje ključne vsebine: